215 related articles for article (PubMed ID: 29069020)
21. The Imbalance between Foxp3
Liang M; Liwen Z; Yun Z; Yanbo D; Jianping C
J Immunol Res; 2018; 2018():3753081. PubMed ID: 30050955
[TBL] [Abstract][Full Text] [Related]
22. Study on early diagnosis of epithelial ovarian cancer by analysis of plasma septin-9 and clusterin level.
Lyu N; Wang Y; Wang J; Zhang Z; Kong W
J Cancer Res Ther; 2018 Jun; 14(Supplement):S444-S449. PubMed ID: 29970704
[TBL] [Abstract][Full Text] [Related]
23. [The significance of change of Th22 cells in patients with acute lymphoblastic leukemia].
Liu LM; Zhang XX; Zhao GS; Si YJ; Lin GQ; Zhang YM; He GS; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2012 Dec; 33(12):985-8. PubMed ID: 23363787
[TBL] [Abstract][Full Text] [Related]
24. Does vitamin D mediate inhibition of epithelial ovarian cancer by modulating cytokines?
Mohapatra S; Saxena A; Gandhi G; Koner BC; Singh T; Ray PC
Clin Transl Oncol; 2015 Aug; 17(8):590-5. PubMed ID: 25740667
[TBL] [Abstract][Full Text] [Related]
25. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.
Dobrzycka B; Terlikowski SJ; Kowalczuk O; Kinalski M
Eur Cytokine Netw; 2009 Sep; 20(3):131-4. PubMed ID: 19825522
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features of imbalance between Th1 and Th22 cells and its association with disease progression in patients with liver cirrhosis].
Wu HQ; Zhao JJ; Li HW; Zhang Z
Zhonghua Gan Zang Bing Za Zhi; 2017 Oct; 25(10):738-744. PubMed ID: 29108201
[No Abstract] [Full Text] [Related]
28. Decreased circulating Th22 and Th17 cells in patients with aplastic anemia.
Lu T; Liu Y; Li P; Yu S; Huang X; Ma D; Ji C
Clin Chim Acta; 2015 Oct; 450():90-6. PubMed ID: 26238188
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of IL-10 and TGF-β levels and myeloid and lymphoid dendritic cells in ovarian cancer patients.
Wertel I; Polak G; Tarkowski R; Kotarska M
Ginekol Pol; 2011 Jun; 82(6):414-20. PubMed ID: 21853929
[TBL] [Abstract][Full Text] [Related]
30. Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes.
Zhao R; Tang D; Yi S; Li W; Wu C; Lu Y; Hou X; Song J; Lin P; Chen L; Sun L
PLoS One; 2014; 9(1):e85770. PubMed ID: 24465695
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients.
Huo J; Hu J; Liu G; Cui Y; Ju Y
Arch Gynecol Obstet; 2017 Feb; 295(2):459-465. PubMed ID: 27975129
[TBL] [Abstract][Full Text] [Related]
32. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
33. Decreased plasma IL-22 levels and correlations with IL-22-producing T helper cells in patients with new-onset systemic lupus erythematosus.
Lin J; Yue LH; Chen WQ
Scand J Immunol; 2014 Feb; 79(2):131-6. PubMed ID: 24313261
[TBL] [Abstract][Full Text] [Related]
34. Th1, Th2, and Th17 Cytokine Involvement in Thyroid Associated Ophthalmopathy.
Shen J; Li Z; Li W; Ge Y; Xie M; Lv M; Fan Y; Chen Z; Zhao D; Han Y
Dis Markers; 2015; 2015():609593. PubMed ID: 26089587
[TBL] [Abstract][Full Text] [Related]
35. A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
Thedrez A; Lavoué V; Dessarthe B; Daniel P; Henno S; Jaffre I; Levêque J; Catros V; Cabillic F
PLoS One; 2013; 8(5):e63322. PubMed ID: 23717410
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Th22, Th17 and CD4
Doulabi H; Rastin M; Shabahangh H; Maddah G; Abdollahi A; Nosratabadi R; Esmaeili SA; Mahmoudi M
Biomed Pharmacother; 2018 Jul; 103():1101-1106. PubMed ID: 29710675
[TBL] [Abstract][Full Text] [Related]
38. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
Farrell AM; Antrobus P; Simpson D; Powell S; Chapel HM; Ferry BL
Br J Dermatol; 2001 Jan; 144(1):24-33. PubMed ID: 11167679
[TBL] [Abstract][Full Text] [Related]
39. Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients.
Peng Z; Dong X; He M; Zhao Y; Liu Y; Li M; Li G; Wang X; Li L; Hu Y
Thorac Cancer; 2023 Nov; 14(33):3282-3294. PubMed ID: 37732365
[TBL] [Abstract][Full Text] [Related]
40. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
